HIGHLIGHTS
- who: Jie Deng et al. from the Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China have published the research work: Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis, in the Journal: (JOURNAL) of 27/04/2022
- what: The authors aimed to review the data available to evaluate and compare the effectiveness and safety of heterologous booster doses with homologous booster doses for severe acute respiratory syndrome coronavirus 2 variance models were used to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.